The Cooper Companies, Inc. $COO Shares Acquired by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 61,843 shares of the medical device company’s stock after buying an additional 1,741 shares during the period. Public Employees Retirement System of Ohio’s holdings in Cooper Companies were worth $4,401,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. JPMorgan Chase & Co. boosted its position in shares of Cooper Companies by 3.4% during the 1st quarter. JPMorgan Chase & Co. now owns 5,177,008 shares of the medical device company’s stock worth $436,681,000 after purchasing an additional 172,485 shares during the period. Goldman Sachs Group Inc. boosted its position in Cooper Companies by 17.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company’s stock valued at $399,340,000 after buying an additional 686,751 shares during the period. Price T Rowe Associates Inc. MD boosted its position in Cooper Companies by 12.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,954,877 shares of the medical device company’s stock valued at $333,595,000 after buying an additional 425,400 shares during the period. Millennium Management LLC boosted its position in Cooper Companies by 36.0% in the 1st quarter. Millennium Management LLC now owns 2,577,416 shares of the medical device company’s stock valued at $217,405,000 after buying an additional 682,166 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Cooper Companies by 15.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,121,835 shares of the medical device company’s stock valued at $178,977,000 after buying an additional 284,943 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have commented on COO shares. Wells Fargo & Company decreased their price target on shares of Cooper Companies from $93.00 to $72.00 and set an “overweight” rating for the company in a research report on Thursday, August 28th. Loop Capital set a $100.00 price target on shares of Cooper Companies in a research report on Tuesday, June 17th. BNP Paribas raised shares of Cooper Companies from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 22nd. UBS Group raised shares of Cooper Companies to a “buy” rating in a research report on Tuesday, June 17th. Finally, Wall Street Zen cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cooper Companies has a consensus rating of “Moderate Buy” and a consensus price target of $86.64.

Cooper Companies Stock Performance

Shares of COO opened at $67.67 on Tuesday. The Cooper Companies, Inc. has a one year low of $61.78 and a one year high of $110.68. The company has a 50-day moving average of $70.06 and a two-hundred day moving average of $74.38. The stock has a market cap of $13.45 billion, a price-to-earnings ratio of 33.34, a PEG ratio of 1.77 and a beta of 0.97. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.07 by $0.03. The business had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The firm’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period last year, the company posted $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies announced that its board has authorized a stock buyback program on Wednesday, September 17th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the medical device company to buy up to 15.4% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s board believes its shares are undervalued.

Insider Transactions at Cooper Companies

In other news, EVP Brian G. Andrews purchased 1,525 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The shares were bought at an average price of $65.68 per share, with a total value of $100,162.00. Following the completion of the transaction, the executive vice president directly owned 22,191 shares in the company, valued at $1,457,504.88. This trade represents a 7.38% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Albert G. White III purchased 10,000 shares of the company’s stock in a transaction dated Friday, September 5th. The stock was purchased at an average cost of $68.39 per share, for a total transaction of $683,900.00. Following the transaction, the chief executive officer owned 226,151 shares of the company’s stock, valued at approximately $15,466,466.89. This trade represents a 4.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 17,975 shares of company stock valued at $1,216,346. Insiders own 1.98% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.